You are viewing: Brazil Mental Health Screening Market analysis
Part of: Mental Health Screening Market (Global)

The Brazil Mental Health Screening Market was valued at $10.55 Million in 2023 and projected to reach to $22.98 Million by 2028, representing a compound annual growth rate of 13.9%. Brazil's mental health screening market is positioned for sustained growth as the country prioritizes mental health within its broader healthcare agenda.

Brazil Mental Health Screening Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Brazil Mental Health Screening Market Trends and Insights

  • This growth trajectory reflects Brazil's increasing recognition of mental health as a critical healthcare priority, driven by rising prevalence of depression, anxiety, and other psychiatric conditions across the population.
  • Brazil's healthcare infrastructure is progressively integrating digital screening tools and standardized assessment protocols to improve early detection and intervention rates. The mental health screening market in Brazil is benefiting from enhanced government initiatives, private sector investment, and growing awareness among healthcare providers and patients alike.
  • Brazil's expanding middle class and improved access to healthcare services are creating favorable conditions for screening adoption across urban and emerging markets.
  • Between 2023 and 2028, Brazil is expected to see accelerated deployment of telemedicine-based screening solutions and workplace mental health programs, positioning the country as a key growth engine within the Latin American mental health sector..

Key Market Statistics

  • CAGR (2023-2028) 13.9% CAGR
  • Market Size, 2023 ~USD 10.55 Million
  • Forecast, 2028 ~USD 22.98 Million
  • Country Brazil

Brazil Mental Health Screening Market Overview

Rapid Market Expansion :

Brazil's mental health screening market is growing at 13.9% CAGR, outpacing the global average of 12.2%, driven by increased awareness and healthcare investment in psychiatric diagnostics.

Rising Mental Health Burden :

Brazil faces escalating prevalence of depression, anxiety, and other psychiatric conditions, creating urgent demand for accessible and efficient mental health screening solutions across urban and emerging healthcare facilities.

Healthcare System Modernization :

Brazil's healthcare sector is increasingly adopting digital screening tools and standardized assessment protocols, particularly within public health systems and private clinics seeking to improve diagnostic accuracy.

Market Valuation Growth :

The market is projected to more than double from USD 10.55 million in 2023 to USD 22.98 million by 2028, reflecting strong investment in mental health infrastructure and screening technologies.

Brazil Mental Health Screening Market Dynamics

  • Government initiatives, coupled with rising private sector investment, are expanding access to screening services across both urban centers and underserved regions.
  • The integration of digital health platforms and telemedicine solutions is accelerating adoption rates among healthcare providers and patients alike. Key drivers include increasing psychiatric disorder prevalence, growing healthcare expenditure, and heightened public awareness campaigns.
  • By 2028, Brazil's market is expected to benefit from regulatory improvements, enhanced reimbursement policies, and technological innovations in screening methodologies.
  • This expansion presents significant opportunities for diagnostic tool manufacturers, healthcare IT providers, and mental health service organizations targeting the Brazilian market..

Related Ecosystem

Healthcare It

Top Technologies
  • Computed Tomography (CT)
  • Machine Learning
  • Magnetic Resonance Imaging (MRI)
  • Natural Language Processing (NLP)
  • Predictive Analytics
Top Companies
  • CERNER CORPORATION
  • PHILIPS HEALTHCARE
  • Oracle Corporation
  • GE HealthCare Technologies Inc.
  • Siemens healthineers

    Key Takeaways

    • Brazil's mental health screening market is projected to more than double from USD 10.55 million in 2023 to USD 22.98 million by 2028, representing a 13.9% CAGR.
    • Brazil's growing mental health awareness and government policy support are driving adoption of standardized screening protocols across public and private healthcare systems.
    • Digital and telemedicine-based screening solutions are rapidly expanding in Brazil, particularly in urban centers and workplace wellness programs.
    • Brazil's expanding middle class and improved healthcare access are creating significant opportunities for mental health screening market penetration through 2028.

    Mental Health Screening Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment COGNITIVE (Application)
    Forecast Period 2023-2028
    Growth Rate CAGR of 12.2% from 2023 to 2028
    Largest Segment ADULTS (AGE 19-64 YEARS) (Age Group)
    Market Size Base Year (Billions) ~USD 0.9 (2023)
    Revenue Forecast (Billions) ~USD 1.6 (2028)
    Segments Covered Application, Type, Screening Method, Technology, Age Group, Setting

    Brazil Mental Health Screening Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Application

    • Behavioral Disorders
    • Cognitive
    • Cognitive Disorders
    • Physiological Disorders
    • Psychiatric Disorders

    By Type

    • Aggression
    • Alzheimer'S Disease
    • Anxiety
    • Attention Deficit Hyperactivity Disorder (Adhd)
    • Beck Depression Inventory (Bdi)
    • Bipolar Disorder
    • Cognitive Impairment
    • Dementia
    • Depression
    • Diagnostic Interview For Psychological Distress (Dipd)
    • Dissociative Disorder
    • Eating Disorder
    • Generalized Anxiety Disorder-7 (Gad-7)
    • Hamilton Anxiety Rating Scale (Ham-A)
    • Hyperactivity
    • Mini International Neuropsychiatric Interview (Mini)
    • Obsessive Compulsive Disorder (Ocd)
    • Other Behavioral Disorders
    • Other Clinical Interviews
    • Other Cognitive Disorders
    • Other Physiological Disorders
    • Other Psychiatric Disorders
    • Other Self-Reported Questionnaires & Surveys
    • Patient Health Questionnaire-12 (Phq-12)
    • Post-Traumatic Stress Disorder (Ptsd)
    • Post-Traumatic Stress Disorder (Ptsd)
    • Psychotic Disorder
    • Schizophrenia
    • Self-Harm
    • Sleep Disorders
    • Social Withdrawal
    • Structured Clinical Interview For Dsm (Scid)
    • Structured Clinical Interviews For Dsm (Scid)
    • Substance Abuse
    • Yale-Brown Obsessive Compulsive Scale (Y-Bocs)

    By Screening Method

    • Biomarker Testing
    • Clinical Interviews
    • Observation-Based Assessments
    • Self-Reported Questionnaires & Surveys

    By Technology

    • AI-Based Screening Tools
    • Continuous Monitoring Wearable Devices
    • Remote Mental Health Platforms
    • Self-Screening Mhealth Apps
    • Telehealth & Virtual Care Solutions

    By Age Group

    • Adults (Age 19-64 Years)
    • Children & Adolescents (0-18 Years)
    • Children & Adolescents (Age 0-18 Years)
    • Seniors (Age 65 And Above)

    By Setting

    • Clinical Settings
    • Educational Institutions
    • Online Platforms
    • Other Settings
    • Workplace/Corporate Programs

    BRAZIL: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    BEHAVIORAL DISORDERS3.944.515.185.966.897.999.0310.3514.8
    COGNITIVE DISORDERS2.322.673.083.574.144.835.496.3115.4
    PHYSIOLOGICAL DISORDERS9.2910.5512.0113.7115.7118.0620.2322.9813.9
    PSYCHIATRIC DISORDERS5.846.547.348.279.3510.611.7213.1312.3
    TOTAL21.3924.2727.6131.5136.0941.4946.4652.7713.8

    Target Audience

    • Diagnostic Tool Manufacturers : Need Brazil-specific market data to assess demand for mental health screening instruments, validate product-market fit, and plan localization strategies for the expanding Brazilian healthcare market.
    • Healthcare IT & Digital Health Companies : Require insights into Brazil's adoption of digital screening platforms, telemedicine integration, and technology infrastructure to develop solutions aligned with local healthcare system requirements and reimbursement models.
    • Investment & Private Equity Firms : Seek comprehensive market analysis to evaluate investment opportunities in Brazilian mental health startups, screening service providers, and healthcare technology companies with high growth potential.
    • Healthcare Providers & Hospital Networks : Need market intelligence to benchmark screening capabilities, identify best-in-class solutions, and make informed procurement decisions for mental health diagnostic services and tools.
    • Pharmaceutical & Biotech Companies : Require Brazil market data to understand screening prevalence, patient populations, and clinical trial recruitment opportunities for psychiatric medications and mental health interventions.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise valuation data for Brazil's mental health screening market with verified CAGR of 13.9%, enabling accurate financial forecasting and investment decision-making for market entry or expansion strategies.
    • Competitive Landscape Intelligence : Understand Brazil-specific market dynamics, key players, and competitive positioning to identify gaps, partnership opportunities, and differentiation strategies within the rapidly expanding mental health screening sector.
    • Regulatory & Reimbursement Insights : Access detailed analysis of Brazil's healthcare policies, reimbursement frameworks, and regulatory requirements for mental health screening products, ensuring compliance and optimized market penetration strategies.
    • Customer Segmentation & Demand Drivers : Identify high-value customer segments including public health systems, private clinics, and corporate wellness programs, with clear understanding of their screening needs and purchasing behaviors specific to Brazil.
    • Strategic Growth Roadmap : Develop data-backed go-to-market strategies leveraging Brazil's projected market growth to USD 22.98M by 2028, with actionable insights on technology adoption, distribution channels, and revenue optimization.

    Frequently asked questions

    What is the current size of Brazil's mental health screening market?

    Brazil's mental health screening market was valued at USD 10.55 million in 2023 and is expected to grow to USD 22.98 million by 2028.

    What is the projected growth rate for Brazil's mental health screening market?

    Brazil's mental health screening market is projected to grow at a compound annual growth rate (CAGR) of 13.9% from 2023 to 2028.

    What factors are driving growth in Brazil's mental health screening market?

    Key drivers include rising mental health awareness, government policy initiatives, digital healthcare adoption, workplace wellness programs, and improved access to healthcare services across Brazil's expanding middle class.

    Which screening technologies are gaining traction in Brazil?

    Telemedicine-based screening solutions, digital assessment tools, and standardized psychiatric screening protocols are rapidly expanding across Brazil's public and private healthcare sectors.

    How does Brazil's market compare to other Latin American countries?

    Brazil represents a significant growth engine within Latin America's mental health screening market, driven by its large population, expanding healthcare infrastructure, and increasing mental health policy prioritization.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Mental Health Screening market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Agency for Healthcare Research and Quality (AHRQ), Primary Care Companion for CNS Disorders Journal, Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital personnel, department heads, hospital directors, corporate personnel) and supply side (such as C-level and D-level executives, technology experts, software developers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    Breakdown of Primary Interviews

    Health Screening Market Size, and Share

    Note 1: Tiers are defined based on the total revenues of companies. As of 2022, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the mental health screening market was arrived at after data triangulation from various approaches, as mentioned below. After completing each approach, a weighted average of the three approaches was taken based on the level of assumptions used in each approach.

    Approach 1: Mental Health Screening Market (Revenue Share Analysis)

    • Revenues for individual companies were gathered from public sources and databases for each market segment.
    • Revenues of private companies were gathered through paid databases such as Factiva and Hoovers.
    • Shares of the mental health screening businesses of leading players were gathered from secondary sources to the extent available. In certain cases, shares have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, and geographic reach.
    • Individual shares or revenue estimates were validated through expert interviews.
    • The market size was then extrapolated to obtain the global market. It was further validated through expert interviews.

    Approach 2: Segmental Extrapolation

    Separate research approaches were followed to estimate the revenue from mental health screening tools and continuous monitoring wearable devices used for mental health screening.

    • Mental health screening tools (excluding continuous monitoring wearable devices):
    • The total number of psychiatrists in the US was determined for 2022. The percentage of psychiatrists using mental health screening tools offered by vendors was identified through extensive secondary research and validated through insights from primary interviews.
    • The average price of mental health screening tools for yearly subscriptions was considered to arrive at the US mental health screening market for clinical settings in 2022.
    • Considering the share of clinical settings, revenues of the overall market in the US were determined for 2022.
    • The US mental health screening market was extrapolated to arrive at the global market.
    • The market for continuous monitoring wearable devices:
    • The total prevalence of mental health disorders in the US was determined for 2022, and the share of people opting for assessments was identified through extensive secondary research and validated through insights from primary interviews.
    • The share of people using continuous monitoring wearable devices for mental health screening was assumed based on secondary research and insights from primary interviews.
    • The average price of continuous monitoring wearable devices was determined through secondary sources to arrive at the US market for continuous monitoring wearable devices.
    • The US market for continuous monitoring wearable devices was extrapolated to arrive at the global market for continuous monitoring wearable devices.
    • The sum of revenues from mental health screening tools and continuous monitoring wearable devices used for mental health screening provided the revenue of the global mental health screening market. The assumptions at each step were validated through primary interviews.

    Approach 3: Primary Interviews

    • As a part of the primary research process, individual respondents’ insights on the market size and growth were taken during the interview (regional and global, as applicable).
    • All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.

    Data Triangulation:

    After arriving at the overall market size, from the market size estimation process explained above, the Mental Health Screening market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Mental Health Screening market.

    Market Definition:

    Mental health screening refers to the process of assessing an individual’s mental health status to identify potential signs or symptoms of mental health conditions. It is a preliminary step in recognizing and addressing mental health concerns early on. The goal of mental health screening is to identify individuals who may be at risk of or experiencing mental health issues so that appropriate interventions, support, or further assessments can be provided.

    Screening tools may include questionnaires, surveys, or interviews that assess various aspects of an individual’s mental health, such as mood, behavior, thoughts, and emotions. These screenings are often administered by healthcare professionals, counselors, or mental health providers in different settings, including schools, workplaces, clinical settings, and others.

    Key Stakeholders:

    • Manufacturers of mental health screening solutions/products
    • Suppliers and distributors of mental health screening solutions/products
    • Third-party refurbishers/suppliers
    • Clinical settings
    • Educational institutions
    • Group purchasing organizations (GPOs)
    • Academic medical centers and universities
    • Corporate entities
    • Community centers
    • Government institutes
    • Market research & consulting firms
    • Contract manufacturing organizations (CMOs)
    • Venture capitalists & investors

    Report Objectives

    • To define, describe, and forecast the mental health screening market by application, screening method, technology, age group, setting, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall mental health screening market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile the key players in the market and comprehensively analyze their market shares and core competencies
    • To forecast the size of the market segments with respect to five main regions: North America, the Asia Pacific, Europe, Latin America, and the Middle East & Africa
    • To track and analyze competitive developments, such as partnerships, acquisitions, and launches
    • To benchmark players within the mental health screening market using the Competitive Evaluation Matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Available Customizations:

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Additional Company Profiling

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe mental health screening market into Spain, Italy, Russia, and others
    • Further breakdown of the Rest of Asia Pacific mental health screening market into Australia, South Korea, Singapore, and others

    Get the Full Mental Health Screening Market Report

    Full forecast, segment splits, and company analysis for all Mental Health Screening Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status